Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents

American Journal of Cardiology

Volumn 113, Issue 2, 2014, Pages 197-202

  Turak, Osman ^a   Canpolat, Uǧur ^a   Özcan, Firat ^a   Mendi, Mehmet Ali ^a   Öksüz, Fatih ^a   Işleyen, Ahmet ^a   Gürel, Özgül Malçok ^b   Çay, Serkan ^a   Aras, Dursun ^a   Aydoǧdu, Sinan ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b TURGUT OZAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; AUTOANALYZER; BARE METAL STENT; COLORIMETRY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ENZYMATIC ASSAY; FEMALE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; URIC ACID BLOOD LEVEL;

EID: 84891629964     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.09.004     Document Type: Article

References (30)

1. G. Niccoli, R.A. Montone, G. Ferrante, and F. Crea The evolving role of inflammatory biomarkers in risk assessment after stent implantation J Am Coll Cardiol 56 2010 1783 1793
2. M.W. Liu, G.S. Roubin, and S.B. King III Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia Circulation 79 1989 1374 1387
3. F.G. Welt, and C. Rogers Inflammation and restenosis in the stent era Arterioscler Thromb Vasc Biol 22 2002 1769 1776
4. R.N. Khouzam, M. Shaheen, R.K. Aziz, and U.N. Ibebuogu The important role of inflammatory biomarkers pre and post bare-metal and drug-eluting stent implantation Can J Cardiol 28 2012 700 705
5. E.B. Kaya, H. Yorgun, U. Canpolat, T. Hazirolan, H. Sunman, A. Ulgen, A.H. Ates, K. Aytemir, L. Tokgozoglu, G. Kabakci, D. Akata, and A. Oto Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography Atherosclerosis 213 2010 178 183
6. J. Kanellis, S. Watanabe, J.H. Li, D.H. Kang, P. Li, T. Nakagawa, A. Wamsley, D. Sheikh-Hamad, H.Y. Lan, L. Feng, and R.J. Johnson Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2 Hypertension 41 2003 1287 1293
7. C. Chaabane, F. Otsuka, R. Virmani, and M.L. Bochaton-Piallat Biological responses in stented arteries Cardiovasc Res 99 2013 353 363
8. E. Braunwald Unstable angina: an etiologic approach to management Circulation 98 1998 2219 2222
9. A. Gaspardone, F. Crea, F. Versaci, F. Tomai, A. Pellegrino, L. Chiariello, and P.A. Gioffre Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina Am J Cardiol 82 1998 515 518
10. C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M.C. Morice, A. Schomig, M.E. Pfisterer, G.W. Stone, M.B. Leon, J.S. de Lezo, J.J. Goy, S.J. Park, M. Sabate, M.J. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M.T. Dirksen, P. Cervinka, A.S. Petronio, A.J. Nordmann, P. Diem, B. Meier, M. Zwahlen, S. Reichenbach, S. Trelle, S. Windecker, and P. Juni Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
11. T. Gürmen, E. BabalIk, M. Gülbaran, S. Öztürk, and M. Öztürk Intracoronary stent implantation: six months results, predictors of stent restenosis Arch Turk Soc Cardiol 26 1998 408
12. T. Inoue, K. Croce, T. Morooka, M. Sakuma, K. Node, and D.I. Simon Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis JACC Cardiovasc Interv 4 2011 1057 1066
13. J.W. Jukema, J.J. Verschuren, T.A. Ahmed, and P.H. Quax Restenosis after PCI. Part 1: pathophysiology and risk factors Nat Rev Cardiol 9 2012 53 62
14. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
15. G. Ferrante, G. Niccoli, L.M. Biasucci, G. Liuzzo, F. Burzotta, L. Galiuto, C. Trani, A.G. Rebuzzi, and F. Crea Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients Cardiovasc Revasc Med 9 2008 156 165
16. A. Pietersma, M. Kofflard, L.E. de Wit, T. Stijnen, J.F. Koster, P.W. Serruys, and W. Sluiter Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment Circulation 91 1995 1320 1325
17. O. Turak, F. Ozcan, A. Isleyen, D. Tok, E. Sokmen, E. Buyukkaya, S. Aydogdu, M. Akpek, and M.G. Kaya Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis Am J Cardiol 110 2012 1405 1410
18. B.M. Rahel, F.L. Visseren, M.J. Suttorp, T.H. Plokker, J.C. Kelder, B.M. de Jongh, K.P. Bouter, and R.J. Diepersloot Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention Cardiovasc Res 60 2003 136 140
19. S. Turker, S. Guneri, B. Akdeniz, M.A. Ozcan, N. Baris, O. Badak, O. Kirimli, and F. Yuksel Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease Am J Cardiol 97 2006 198 202
20. R.P. Juni, H.J. Duckers, P.M. Vanhoutte, R. Virmani, and A.L. Moens Oxidative stress and pathological changes after coronary artery interventions J Am Coll Cardiol 61 2013 1471 1481
21. C.E. Berry, and J.M. Hare Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications J Physiol 555 2004 589 606
22. F.J. Nieto, C. Iribarren, M.D. Gross, G.W. Comstock, and R.G. Cutler Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 148 2000 131 139
23. A. Sevanian, K.J. Davies, and P. Hochstein Serum urate as an antioxidant for ascorbic acid Am J Clin Nutr 54 1991 1129S 1134S
24. A. So, and B. Thorens Uric acid transport and disease J Clin Investig 120 2010 1791 1799
25. E. Krishnan, B.J. Pandya, L. Chung, and O. Dabbous Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study Arth Res Ther 13 2011 R66
26. T. Neogi, R.C. Ellison, S. Hunt, R. Terkeltaub, D.T. Felson, and Y. Zhang Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study J Rheumatol 36 2009 378 384
27. T. Lyngdoh, P. Marques-Vidal, F. Paccaud, M. Preisig, G. Waeber, M. Bochud, and P. Vollenweider Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study PLoS One 6 2011 e19901
28. D.H. Kang, S.K. Park, I.K. Lee, and R.J. Johnson Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells J Am Soc Nephrol 16 2005 3553 3562
29. G.N. Rao, M.A. Corson, and B.C. Berk Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression J Biol Chemist 266 1991 8604 8608
30. Y. Yamamoto, K. Ogino, G. Igawa, T. Matsuura, Y. Kaetsu, S. Sugihara, K. Matsubara, J. Miake, T. Hamada, A. Yoshida, O. Igawa, T. Yamamoto, C. Shigemasa, and I. Hisatome Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats Hypertens Res 29 2006 915 921